Patient assistance programs are often the difference between accessing the drug and increasing abandonment rate.
Jayson S. Slotnick, JD
Advertisement
Articles by Jayson S. Slotnick, JD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Adds a New Sunscreen to the OTC Repertoire
2
EPCORE DLBCL-1 Trial Demonstrates Durable Responses, PFS Benefit With Epcoritamab in RR LBCL
3
Gemcitabine Intravesical System: A Novel Treatment Option for BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
4
NLA 2026: Evolocumab Cuts Cardiovascular Events in High-Risk Patients Before First MI or Stroke
5